Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報

◆英語タイトル:Exalenz Bioscience Ltd (EXEN) - Medical Equipment - Deals and Alliances Profile
◆商品コード:DATA904C7093
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イスラエル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Exalenz Bioscience Ltd (Exalenz) carries out the development and commercialization of advanced medical systems for a range of gastrointestinal (GI) tract and liver disorders. The company harnesses its BreathID technology platform for assessment and monitoring of functional diseases. Its flagship product, BreathID Hp is a US FDA approved and CE marked urea breath test for diagnosing, monitoring and managing gastric Helicobacter pylori (H. pylori) infection in adults. It also offers BreathID 13C-methacetin breath test, a non-invasive point of care tool measures the microsomal function of the liver. It works in collaboration with various clinical and industrial partners in Europe, Asia, the US and Israel. Exalenz is headquartered in Modiin, Israel.

Exalenz Bioscience Ltd (EXEN) – Medical Equipment – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exalenz Bioscience Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exalenz Bioscience Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Exalenz Bioscience Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exalenz Bioscience Ltd, Medical Equipment, Deal Details 10
Partnerships 10
Exalenz Bioscience Partners with Conatus Pharma 10
Exalenz Bioscience Enters into Agreement with ALFSG 11
Equity Offering 12
Exalenz Bioscience Files Registration Statement to Raise Funds through Public Offering of Shares 12
Exalenz Bioscience Completes Rights Offering Of Shares For US$7.8 Million 13
Exalenz Bioscience Ltd – Key Competitors 14
Exalenz Bioscience Ltd – Key Employees 15
Exalenz Bioscience Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Financial Announcements 17
Aug 31, 2018: Exalenz Bioscience announces second quarter 2018 financial results 17
Mar 12, 2018: Exalenz Announces Fourth Quarter and Full Year 2017 Financial Results 19
Corporate Communications 20
Apr 30, 2018: Exalenz Bioscience Appoints Roy Golan as President and Chief Financial Officer 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
Exalenz Bioscience Ltd, Medical Equipment, Key Facts, 2017 2
Exalenz Bioscience Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exalenz Bioscience Ltd, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exalenz Bioscience Ltd, Deals By Market, 2012 to YTD 2018 8
Exalenz Bioscience Ltd, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Exalenz Bioscience Partners with Conatus Pharma 10
Exalenz Bioscience Enters into Agreement with ALFSG 11
Exalenz Bioscience Files Registration Statement to Raise Funds through Public Offering of Shares 12
Exalenz Bioscience Completes Rights Offering Of Shares For US$7.8 Million 13
Exalenz Bioscience Ltd, Key Competitors 14
Exalenz Bioscience Ltd, Key Employees 15
Exalenz Bioscience Ltd, Subsidiaries 16

List of Figures
Exalenz Bioscience Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Exalenz Bioscience Ltd, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Exalenz Bioscience Ltd, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Exalenz Bioscience Ltd, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Exalenz Bioscience Ltd, Medical Equipment, Deals by Market, 2012 to YTD 2018 8

★海外企業調査レポート[Exalenz Bioscience Ltd (EXEN):医療機器:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Transdev Group SA:企業の戦略的SWOT分析
    Transdev Group SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • Larsen & Toubro Infotech Ltd (LTI):企業の財務・戦略的SWOT分析
    Larsen & Toubro Infotech Ltd (LTI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Panhandle Oil and Gas Inc (PHX):企業の財務・戦略的SWOT分析
    Panhandle Oil and Gas Inc (PHX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Devoteam Sa
    Devoteam Sa - Strategy, SWOT and Corporate Finance Report Summary Devoteam Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Taiheiyo Cement Corporation:企業の戦略・SWOT・財務分析
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Nektar Therapeutics (NKTR):企業の財務・戦略的SWOT分析
    Nektar Therapeutics (NKTR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • FLSmidth & Co AS (FLS):企業の財務・戦略的SWOT分析
    FLSmidth & Co AS (FLS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Subsea 7 SA (SUBC):電力:M&Aディール及び事業提携情報
    Summary Subsea 7 SA (Subsea 7) is a contractor in seabed-to-surface engineering, construction and services. The company provides engineering, project management, supply chain, and vessel management services. It connects seabed wellhead structures to surface facilities, such as platforms and floating …
  • HTG Molecular Diagnostics Inc (HTGM):製薬・医療:M&Aディール及び事業提携情報
    Summary HTG Molecular Diagnostics Inc (HTG) is a technology company that provides molecular technology solutions. The company provides products such as HTG edge system, HTG edgeseq reagents and HTG edgeseq immuno-oncology biomarker panel assay, among others. It develops assays and reagent systems th …
  • Redington (India) Ltd (REDINGTON):企業の財務・戦略的SWOT分析
    Redington (India) Ltd (REDINGTON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • UNIQA Ukraine:企業の戦略・SWOT・財務情報
    UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report Summary UNIQA Ukraine - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • NIKE Inc:企業の戦略・SWOT・財務情報
    NIKE Inc - Strategy, SWOT and Corporate Finance Report Summary NIKE Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Antitope Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Antitope Ltd (Antitope), a subsidiary of Abzena Plc is a life science company that research and develops technologies for various therapeutic areas. The company’s iTope technology is used to identify peptides; and T cell epitope database is used for screening amino acid sequences from antibo …
  • Bio Techne Corp (TECH):製薬・医療:M&Aディール及び事業提携情報
    Summary Bio Techne Corp (Bio Techne), formerly Techne, develops, produces, and markets biotechnology products and scientific tools to understand biological processes and drive research. The company’s portfolio encompasses native and recombinant proteins, monoclonal and polyclonal antibodies, immunoa …
  • Tokuyama Corp (4043)
    Tokuyama Corp (4043) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Litha Healthcare Group Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Litha Healthcare Group Ltd (Litha Healthcare), formerly Myriad Medical Holdings Limited, a subsidiary of Endo International plc is a healthcare company that provides its services to public and private hospitals, pharmacies, general, allied practitioners, and government healthcare programmes. …
  • F-Secure Oyj (FSC1V):企業の財務・戦略的SWOT分析
    F-Secure Oyj (FSC1V) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • British American Tobacco Plc (BATS):企業の財務・戦略的SWOT分析
    British American Tobacco Plc (BATS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Bord na Mona Plc:企業の戦略的SWOT分析
    Bord na Mona Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Petroleo Brasileiro SA (PETR4):石油・ガス:M&Aディール及び事業提携情報
    Summary Petroleo Brasileiro SA (Petrobras) is an integrated oil and gas company. Its major businesses include exploration and production, refining, marketing, trade and transportation of oil and gas. The company also conducts biofuel, petrochemical, natural gas, electricity and chemical businesses, …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆